Luc M Berclaz

3PUBLICATIONS
5CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jun 05, 2026
Machine Learning-Guided Survival Prediction and Treatment Sequencing in Advanced Soft Tissue Sarcoma Beyond Second-Line Therapy: A Retrospective Cohort Study.

|Feb 26, 2025
Doxorubicin Plus Dacarbazine Versus Doxorubicin Plus Ifosfamide in Combination With Regional Hyperthermia in Patients With Advanced Leiomyosarcoma: A Propensity Score-Matched Analysis.

Luc M Berclaz, Vindi Jurinovic, Anton Burkhard-Meier

|Jun 22, 2023
TIM-3 Qualifies as a Potential Immunotherapeutic Target in Specific Subsets of Patients with High-Risk Soft Tissue Sarcomas (HR-STS).

Luc M Berclaz, Annelore Altendorf-Hofmann, Lars H Lindner

Pageof 1

Frequent Collaborators

2 joint publications

Hans Roland Dürr

2 joint publications

Markus Albertsmeier

1 joint publications

Lars H Lindner

1 joint publications

Alexander Klein